Scienture (SCNX) News Today $0.73 +0.01 (+1.24%) Closing price 04:00 PM EasternExtended Trading$0.71 -0.02 (-3.16%) As of 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Scienture announces repayment, conversion of outstanding debenturesOctober 8, 2025 | msn.comSCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance SheetOctober 8, 2025 | markets.businessinsider.comScienture Holdings Amends Bylaws for Quorum ChangeOctober 7, 2025 | msn.comScienture Holdings Amends Convertible Debentures AgreementOctober 3, 2025 | tipranks.comScienture (NASDAQ:SCNX) Trading Down 0.9% - Here's What HappenedOctober 3, 2025 | americanbankingnews.comSCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare InstitutionsOctober 1, 2025 | finance.yahoo.comScienture Holdings, Inc. Secures GPO Agreements for Arbli™ Oral Suspension, Expanding Access to U.S. Institutional MarketOctober 1, 2025 | quiverquant.comQEXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare InstitutionsOctober 1, 2025 | benzinga.comScienture Holdings Enters Equity Distribution AgreementSeptember 23, 2025 | tipranks.comScienture formalizes major commercial PBM led by GPO rebate agreementSeptember 16, 2025 | msn.comScienture Holdings, Inc. Announces Major Rebate Agreement for Arbli™ Liquid Losartan, Enhancing Access for Over 100 Million LivesSeptember 16, 2025 | quiverquant.comQSCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan MarketSeptember 16, 2025 | globenewswire.comScienture files to sell 2.1M shares of common stock for holdersAugust 25, 2025 | msn.comScienture prices 3.23M shares at $1.20 in registered direct offeringAugust 14, 2025 | msn.comScienture stock plummets after announcing $3.9 million registered offeringAugust 14, 2025 | investing.comScienture Shares Plunge After $3.9 Million Discounted Offering AnnouncementAugust 14, 2025 | msn.comScienture Holdings, Inc. Announces Pricing of $3. ...August 14, 2025 | gurufocus.comScienture Holdings, Inc. Announces $3.9 Million Registered Direct Offering of Common StockAugust 14, 2025 | quiverquant.comQScienture Holdings, Inc. Announces Pricing of $3. ...August 14, 2025 | gurufocus.comScienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common StockAugust 14, 2025 | globenewswire.comScienture announces shipment of launch quantities of Arbli Oral SuspensionAugust 13, 2025 | msn.comScienture Holdings, Inc. to Launch Arbli™ Oral Suspension for Hypertension Treatment in the U.S. marketAugust 13, 2025 | quiverquant.comQSCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.August 13, 2025 | globenewswire.comScienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding | SCNX Stock NewsJuly 24, 2025 | gurufocus.comScienture Holdings Secures $1.2 Million in Capital RaiseJuly 24, 2025 | tipranks.comScienture Holdings, Inc. Secures $3 Million Bridge Funding to Support Product Launches and Pipeline DevelopmentJuly 24, 2025 | quiverquant.comQScienture Holdings, Inc. Obtains $1.2 Million in Bridge FundingJuly 24, 2025 | globenewswire.comScienture Holdings, Inc. Regains Compliance with Nasdaq Listing ...July 18, 2025 | nasdaq.comScienture Holdings Inc News (SCNX) - Investing.comJuly 18, 2025 | investing.comScienture Holdings, Inc. Regains Compliance with Nasdaq Listing RequirementsJuly 16, 2025 | globenewswire.comScienture Holdings Secures Indemnification for LeadershipJuly 3, 2025 | tipranks.comScienture Holdings Announces Cancelation of ELOCJune 17, 2025 | globenewswire.comSCIENTURE Announces Executive Leadership TransitionMay 22, 2025 | globenewswire.comSCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.May 19, 2025 | globenewswire.comScienture initiates supply chain activities by subsidiary to launch ArbliApril 24, 2025 | markets.businessinsider.comScienture Holdings, Inc. Announces Supply Chain Readiness for Launch of FDA-Approved ArbliTM Oral Suspension in July 2025April 22, 2025 | quiverquant.comQSCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.April 22, 2025 | globenewswire.comScienture Holdings Divests Subsidiaries to Tollo HealthApril 11, 2025 | tipranks.comSCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment ...April 10, 2025 | seekingalpha.comScienture divests Integra Pharma Solutions, Bonum Health, Softell for $5MApril 10, 2025 | markets.businessinsider.comSCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.April 8, 2025 | globenewswire.comScienture files to sell 2.64M shares of common stock for holdersApril 5, 2025 | markets.businessinsider.comScienture CEO says focused on execution, growth, expansion for years aheadApril 4, 2025 | markets.businessinsider.comScienture Holdings, Inc. Issues Annual Letter to ShareholdersApril 3, 2025 | globenewswire.comSCNX Scienture Holdings, Inc.April 2, 2025 | seekingalpha.comScienture appoints Rath as CCO, enters agreement with SyneosMarch 25, 2025 | markets.businessinsider.comSCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales OrganizationMarch 25, 2025 | globenewswire.comScienture announces draaw on Equity Line of CreditMarch 20, 2025 | markets.businessinsider.comScienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading DaysMarch 19, 2025 | globenewswire.comScienture announces U.S. FDA approval of NDA for SCN-102March 19, 2025 | markets.businessinsider.com Get Scienture News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SCNX Media Mentions By Week SCNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCNX News Sentiment▼0.790.75▲Average Medical News Sentiment SCNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCNX Articles This Week▼51▲SCNX Articles Average Week Get the Latest News and Ratings for SCNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Scienture and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies WGRX News Today NHTC News Today RAVE News Today COSM News Today BANL News Today DTCK News Today HWH News Today TAIT News Today HYFM News Today EDUC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCNX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
